Skip to main content
Erschienen in: Journal of General Internal Medicine 7/2020

08.01.2020 | Original Research

Dense Breast Notification Laws, Education, and Women’s Awareness and Knowledge of Breast Density: a Nationally Representative Survey

verfasst von: Kelly A. Kyanko, MD, MHS, Jessica Hoag, PhD, Susan H. Busch, PhD, Jenerius A. Aminawung, MD, MPH, Xiao Xu, PhD, Ilana B. Richman, MD, Cary P. Gross, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

To date, 38 states have enacted dense breast notification (DBN) laws mandating that mammogram reports include language informing women of risks related to dense breast tissue.

Objective

Nationally representative survey to assess the association between residing in a state with a DBN law and women’s awareness and knowledge about breast density, and breast cancer anxiety.

Design

Internet survey conducted in 2018 with participants in KnowledgePanel®, an online research panel.

Participants

English-speaking US women ages 40–59 years without a personal history of breast cancer who had received at least one screening mammogram (N = 1928; survey completion rate 68.2%).

Main Measures

(1) Reported history of increased breast density, (2) knowledge of the increased risk of breast cancer with dense breasts, (3) knowledge of the masking effect of dense breasts on mammography, and (4) breast cancer anxiety.

Key Results

Women residing in DBN states were more likely to report increased breast density (43.6%) compared with women residing in non-DBN states (32.7%, p < 0.01, adjusted odds ratio, 1.70, 95% CI,1.34–2.17). Interaction effect between DBN states and education status showed that the impact of DBN on women’s reporting of dense breasts was significant for women with greater than high school education, but not among women with a high school education or less (p value = 0.01 for interaction). Only 23.0% of women overall knew that increased breast density was associated with a higher risk of breast cancer, and 68.0% of women understood that dense breasts decreased the sensitivity of mammography. There were no significant differences between women in DBN states and non-DBN states for these outcomes, or for breast cancer–related anxiety.

Conclusions

State DBN laws were not associated with increased understanding of the clinical implications of breast density. DBN laws were associated with a higher likelihood of women reporting increased breast density, though not among women with lower education.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. Journal of the National Cancer Institute. 2014;106(10). Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. Journal of the National Cancer Institute. 2014;106(10).
2.
Zurück zum Zitat Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Annals of Internal Medicine. 2012;156(9):635–648. Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Annals of Internal Medicine. 2012;156(9):635–648.
3.
Zurück zum Zitat Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Annals of Internal Medicine. 2011;155(8):493–502. Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Annals of Internal Medicine. 2011;155(8):493–502.
5.
Zurück zum Zitat Haas JS, Kaplan CP. The divide between breast density notification laws and evidence-based guidelines for breast cancer screening: legislating practice. JAMA Internal Medicine. 2015;175(9):1439–1440. Haas JS, Kaplan CP. The divide between breast density notification laws and evidence-based guidelines for breast cancer screening: legislating practice. JAMA Internal Medicine. 2015;175(9):1439–1440.
6.
Zurück zum Zitat Slanetz PJ, Freer PE, Birdwell RL. Breast-density legislation—practical considerations. New England Journal of Medicine. 2015;372(7):593–595.CrossRef Slanetz PJ, Freer PE, Birdwell RL. Breast-density legislation—practical considerations. New England Journal of Medicine. 2015;372(7):593–595.CrossRef
7.
Zurück zum Zitat Keating NL, Pace LE. New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients? JAMA. 2019. Keating NL, Pace LE. New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients? JAMA. 2019.
8.
Zurück zum Zitat Kressin NR, Gunn CM, Battaglia TA. Content, readability, and understandability of dense breast notifications by state. JAMA. 2016;315(16):1786–1788. Kressin NR, Gunn CM, Battaglia TA. Content, readability, and understandability of dense breast notifications by state. JAMA. 2016;315(16):1786–1788.
9.
Zurück zum Zitat Gunn CM, Battaglia TA, Paasche-Orlow MK, West AK, Kressin NR. Women’s perceptions of dense breast notifications in a Massachusetts safety net hospital:“So what is that supposed to mean?”. Patient education and counseling. 2018;101(6):1123–1129.CrossRef Gunn CM, Battaglia TA, Paasche-Orlow MK, West AK, Kressin NR. Women’s perceptions of dense breast notifications in a Massachusetts safety net hospital:“So what is that supposed to mean?”. Patient education and counseling. 2018;101(6):1123–1129.CrossRef
10.
Zurück zum Zitat Jemal A, Ward E, Henley J, et al. Cancer Mortality in the United States by Education Level and Race. Journal of the National Cancer Institute. 2007;99(18):1384–1394. Jemal A, Ward E, Henley J, et al. Cancer Mortality in the United States by Education Level and Race. Journal of the National Cancer Institute. 2007;99(18):1384–1394.
11.
Zurück zum Zitat Sprague BL, Trentham-Dietz A, Gangnon RE, et al. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer. 2011;117(7):1542–1551.CrossRef Sprague BL, Trentham-Dietz A, Gangnon RE, et al. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer. 2011;117(7):1542–1551.CrossRef
13.
Zurück zum Zitat Rhodes DJ, Breitkopf CR, Ziegenfuss JY, Jenkins SM, Vachon CM. Awareness of breast density and its impact on breast cancer detection and risk. Journal of Clinical Oncology. 2015;33(10):1143.CrossRef Rhodes DJ, Breitkopf CR, Ziegenfuss JY, Jenkins SM, Vachon CM. Awareness of breast density and its impact on breast cancer detection and risk. Journal of Clinical Oncology. 2015;33(10):1143.CrossRef
14.
Zurück zum Zitat Cappello NM, Richetelli D, Lee CI. The Impact of Breast Density Reporting Laws on Women’s Awareness of Density-Associated Risks and Conversations Regarding Supplemental Screening With Providers. Journal of the American College of Radiology. 2019;16(2):139–146.CrossRef Cappello NM, Richetelli D, Lee CI. The Impact of Breast Density Reporting Laws on Women’s Awareness of Density-Associated Risks and Conversations Regarding Supplemental Screening With Providers. Journal of the American College of Radiology. 2019;16(2):139–146.CrossRef
15.
Zurück zum Zitat Guterbock TM, Cohn WF, Rexrode DL, et al. What do women know about breast density? Results from a population survey of Virginia women. Journal of the American College of Radiology. 2017;14(1):34–44.CrossRef Guterbock TM, Cohn WF, Rexrode DL, et al. What do women know about breast density? Results from a population survey of Virginia women. Journal of the American College of Radiology. 2017;14(1):34–44.CrossRef
16.
Zurück zum Zitat Houssami N, Lee CI. The impact of legislation mandating breast density notification - Review of the evidence. Breast (Edinburgh, Scotland). 2018;42:102–112.CrossRef Houssami N, Lee CI. The impact of legislation mandating breast density notification - Review of the evidence. Breast (Edinburgh, Scotland). 2018;42:102–112.CrossRef
17.
Zurück zum Zitat Miles RC, Lehman C, Warner E, Tuttle A, Saksena M. Patient-Reported Breast Density Awareness and Knowledge after Breast Density Legislation Passage. Academic Radiology Jun 2019;26(6):726–731. Miles RC, Lehman C, Warner E, Tuttle A, Saksena M. Patient-Reported Breast Density Awareness and Knowledge after Breast Density Legislation Passage. Academic Radiology Jun 2019;26(6):726–731.
18.
Zurück zum Zitat Willis GB. Cognitive interviewing: A tool for improving questionnaire design. Sage Publications; Thousand Oaks 2004. Willis GB. Cognitive interviewing: A tool for improving questionnaire design. Sage Publications; Thousand Oaks 2004.
19.
Zurück zum Zitat Yeager DS, Krosnick JA, Chang L, et al. Comparing the accuracy of RDD telephone surveys and internet surveys conducted with probability and non-probability samples. Public Opinion Quarterly. 2011;75(4):709–747. Yeager DS, Krosnick JA, Chang L, et al. Comparing the accuracy of RDD telephone surveys and internet surveys conducted with probability and non-probability samples. Public Opinion Quarterly. 2011;75(4):709–747.
22.
Zurück zum Zitat Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value in health. 2007;10(4):294–304.CrossRef Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value in health. 2007;10(4):294–304.CrossRef
23.
Zurück zum Zitat Norton EC, Dowd BE, Maciejewski ML. Marginal Effects—Quantifying the Effect of Changes in Risk Factors in Logistic Regression Models. JAMA. 2019: 321:1304-1305CrossRef Norton EC, Dowd BE, Maciejewski ML. Marginal Effects—Quantifying the Effect of Changes in Risk Factors in Logistic Regression Models. JAMA. 2019: 321:1304-1305CrossRef
24.
Zurück zum Zitat Smetana GW, Elmore JG, Lee CI, Burns RB. Should This Woman With Dense Breasts Receive Supplemental Breast Cancer Screening?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals of Internal Medicine. 2018;169(7):474–484. Smetana GW, Elmore JG, Lee CI, Burns RB. Should This Woman With Dense Breasts Receive Supplemental Breast Cancer Screening?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals of Internal Medicine. 2018;169(7):474–484.
25.
Zurück zum Zitat Kindig DA, Panzer AM, Nielsen-Bohlman L. Health literacy: a prescription to end confusion. National Academies Press; Washington, D. C. 2004. Kindig DA, Panzer AM, Nielsen-Bohlman L. Health literacy: a prescription to end confusion. National Academies Press; Washington, D. C. 2004.
Metadaten
Titel
Dense Breast Notification Laws, Education, and Women’s Awareness and Knowledge of Breast Density: a Nationally Representative Survey
verfasst von
Kelly A. Kyanko, MD, MHS
Jessica Hoag, PhD
Susan H. Busch, PhD
Jenerius A. Aminawung, MD, MPH
Xiao Xu, PhD
Ilana B. Richman, MD
Cary P. Gross, MD
Publikationsdatum
08.01.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 7/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05590-7

Weitere Artikel der Ausgabe 7/2020

Journal of General Internal Medicine 7/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.